CoChat

Morbidity and Mortality Associated With Medications Used in the Treatment of Depression: An Analysis of Cases Reported to U.S. Poison Control Centers, 2000–2014

Nelson, J. Craig, Spyker, Daniel A. · 2017 · American Journal of Psychiatry

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: The authors sought to determine the relative morbidity and mortality associated with drugs used to treat depression and to examine specific clinical effects associated with serious outcomes. METHOD: The National Poison Data System, which receives exposure reports from regional poison centers serving the United States, Puerto Rico, and the District of Columbia, was queried for single drug exposures in individuals 12 years and older during the period 2000-2014. Medications included were antidepressants, atypical antipsychotics, anticonvulsants, lithium, and other medications used in the treatment of depression. The main outcomes were the morbidity index (the number of serious outcomes per 1,000 exposures) and the mortality index (the number of fatal outcomes per 10,000 exposures). RESULTS: During this 15-year period, there were 962,222 single substance exposures to the 48 medications studied. Serious outcomes rose 2.26-fold and in linear fashion over the 15 years. While tricyclic and monoamine oxidase inhibitor medications were associated with high morbidity and mortality, several newer agents also appeared hazardous. Lithium, quetiapine, olanzapine, bupropion, and carbamazepine were associated with high morbidity indices. Lithium, venlafaxine, bupropion, quetiapine, olanzapine, ziprasidone, valproic acid, carbamazepine, and citalopram were associated with higher mortality indices. CONCLUSIONS: Serious outcomes after overdose or nonintentional exposures to medications used to treat depression have risen dramatically over the past 15 years. The present data suggest that the morbidity and mortality risks vary substantially among these medications. These differences become important when selecting treatments for patients with depression, especially those at increased risk for suicide.

Overview

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2016.16050523

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 42 references

Research works printed but not linked: 3

  1. 10.1001/jama.1987.03390040137034 · DOI
  2. Barbey JT, 1998, J Clin Psychiatry, 59, 42
  3. Hashimoto H, 1990, Arch Int Pharmacodyn Ther, 304, 181

Cited by

See all 67

Metadata

Authors
Nelson, J. C., & Spyker, D. A.
Affiliations
Oregon Health & Science University (US)
Venue
American Journal of Psychiatry
Published
2017-05-01
Volume
174
Issue
5
Pages
438-450
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2584620255
Cited by
67
References
42
Citations by year
2026: 1 · 2025: 5 · 2024: 8 · 2023: 6 · 2022: 5 · 2021: 10 · 2020: 7 · 2019: 10 · 2018: 10 · 2017: 5
FWCI
11.24
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
depression treatment, antidepressants, drug overdose, poisoning, morbidity, mortality, poison control centers, tricyclic antidepressants, monoamine oxidase inhibitors, lithium, atypical antipsychotics, bupropion, quetiapine, olanzapine, carbamazepine, suicide risk, drug safety
MeSH terms
Adolescent, Adult, Anticonvulsants, Antidepressive Agents, Cause of Death, Child, Depressive Disorder, Female, Humans, Male, Poison Control Centers, Risk, Suicide, Antipsychotic Agents, United States, Proportional Hazards Models, Adverse Drug Reaction Reporting Systems, Lithium Compounds, Young Adult, Drug Overdose

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Morbidity and Mortality Associated With Medications Used in the Treatment of Depression: An Analysis of Cases Reported to U.S. Poison Control Centers, 2000–2014. https://app.cochat.ai/papers/10.1176/appi.ajp.2016.16050523
The paper
Nelson, J. C., & Spyker, D. A. (2017). Morbidity and Mortality Associated With Medications Used in the Treatment of Depression: An Analysis of Cases Reported to U.S. Poison Control Centers, 2000–2014. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2016.16050523

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.